MedBen Rx Blog
Be Proactive about Biologics’ Growing Popularity
From earlier this year: “The global biologics market is expected to see a 12% growth rate and reach $420.55 billion by 2025, according to a new report by The Business Research Company.” A drug therapy originating from living organisms, biologics is a...
Don’t Be an ATM for Your PBM!
Major pharmacy benefit managers (PBMs) use “smoke and mirrors” to make you believe they’re saving you money on prescription drugs: On the one hand, PBMs offer you administrative fee credits – fixed cost reductions that make up just a small...
MedBen Rx Offers Unique Savings Opportunity
Hospitals and other qualified entities have a unique opportunity for pharmacy savings through Own Use. This innovative program can save MedBen Rx clients as much as 35% when compared to standard PBM pricing.Own Use brings together non-profit health care systems and...
Combat High-cost Drug Marketing with Comparative Effectiveness
From Benefits Pro: “The median launch price of a new drug in the US soared from $2,115 in 2008 to $180,007 in 2021, a 20% annual inflation rate over the period, researchers at Harvard-affiliated Brigham and Women’s Hospital in Boston found.”Contributing to these...
Avoid the PBM Rebate Games
MedBen Rx has prepared a whitepaper detailing the games pharmacy benefit managers (PBMs) play with administrative and rebate credits. PBMs focus on fixed cost savings to make you think you’re saving on prescription costs… but a closer look reveals that you’re...
MedBen Rx = Lower Cost with Better Outcomes and Complete Transparency
U.S. spending on prescription drugs have returned to pre-pandemic levels and member out-of-pocket costs continue to increase, so it’s the right time to explore pharmacy solutions that offer clinically-effective, lower-cost solutions. MedBen Rx delivers on both counts....
Download the 2022 MedBen Client Report Now!
Download the 2022 MedBen Client Report Now! This year’s Client Report focuses on: New solutions like MedBen Rx comparative effectiveness, air ambulance reviews, No Surprises Act administrative services, and HealthJoy TPA+, as well as improvements to our MedBen...
MedBen Rx Comparative Effectiveness Saves Client $2.89 Million
MedBen Rx comparative effectiveness represents the next generation of pharmacy solutions, saving the employer money while also impacting member health. One such client recently engaged MedBen Rx to help them implement a pharmacy benefit design driven by clinical...
MedBen Rx Solutions Let You Call the Shots
Pharmacy benefit managers (PBMs) are profiting at the expense of consumers and payers, finds a new report from the PBM Accountability Group. MedBen Rx counters such tactics with pharmacy solutions that ensure you know exactly what a drug costs. From Benefits Pro:...
Many Drugs Seeing Price Increases in 2022
By January 17, 669 drugs will have experienced price increases, with an average increase of 5.0%. All but 11 on the list are brand-name medications.
MedBen Rx Solutions Lower Health System’s Costs by $4.6 Million
In their first year with MedBen Rx, a regional health system lowered costs by $4.6 million through pharmacy savings and added revenue. This includes a 30% reduction in employee pharmacy plan spend. The health system had previously entered into three-year agreement...
Save 10-40% on Rx Costs by Using the Most Effective Drugs
MedBen Rx comparative effectiveness brings clinical research and employers together to find the most effective drugs at the best cost. You can save 10-40% on pharmacy costs by changing to drugs with better outcomes. The benefits of comparative effectiveness include:...